Molecular testing has become increasingly important in thyroid cytopathology. Tests for genetic mutations and rearrangements, such as BRAF, RAS, and RET/PTC, can provide additional diagnostic information, particularly in indeterminate cases. These tests help predict the behavior of thyroid nodules and guide therapeutic decisions.
